2 months ago
MNMD
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 4%
#175 out of 4587 analysts
Average Return
+13.87%
Win Rate
51%89 out of 173
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-10 - 2024-03-08 | Buy |
Mind Medicine IncMNMD | +212.55% | $2.63 | $8.22 | 2023-10-23 - 2024-05-17 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | 2 | Buy | $77.00 | +71.11% | Initiates Coverage On | 7 days ago |
Pliant Therapeutics IncPLRX | 11 | Buy | $45.00 | +194.70% | Maintains | 13 days ago |
Vertex Pharmaceuticals IncVRTX | 41 | Hold | $424.00 | -4.76% | Maintains | 13 days ago |
Contineum Therapeutics IncCTNM | 1 | Buy | $30.00 | +93.55% | Initiates Coverage On | 20 days ago |
Sage Therapeutics IncSAGE | 17 | Hold | $15.00 | +28.21% | Maintains | 24 days ago |
Gilead Sciences IncGILD | 18 | Hold | $74.00 | +9.27% | Maintains | 24 days ago |
Marinus Pharmaceuticals IncMRNS | 7 | Hold | $3.00 | +125.56% | Downgrades | a month ago |
Applied Therapeutics IncAPLT | 2 | Buy | $12.00 | +186.40% | Reiterates | a month ago |
Regeneron Pharmaceuticals IncREGN | 18 | Buy | $1,189.00 | +21.04% | Reiterates | a month ago |
Intra Cellular Therapies IncITCI | 13 | Buy | $86.00 | +32.31% | Reiterates | 2 months ago |
Neumora Therapeutics IncNMRA | 3 | Buy | $31.00 | +220.58% | Reiterates | 2 months ago |
Incyte CorpINCY | 12 | Hold | $65.00 | +13.84% | Reiterates | 2 months ago |
Hookipa Pharma IncHOOK | 7 | Buy | $5.00 | +513.50% | Reiterates | 2 months ago |
Ptc Therapeutics IncPTCT | 12 | Hold | $28.00 | -15.40% | Reiterates | 2 months ago |
Igm Biosciences IncIGMS | 11 | Buy | $21.00 | +127.77% | Reiterates | 2 months ago |
Mind Medicine IncMNMD | 8 | Buy | $22.00 | +167.64% | Maintains | 2 months ago |
Biogen IncBIIB | 24 | Buy | $364.00 | +57.87% | Reiterates | 3 months ago |
Xenon Pharmaceuticals IncXENE | 11 | Buy | $55.00 | +38.19% | Maintains | 3 months ago |
89bio IncETNB | 12 | Hold | $14.00 | +62.22% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 18 | Buy | $157.00 | +19.50% | Maintains | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 7 | Hold | $35.00 | +55.42% | Maintains | 3 months ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | +14.29% | Maintains | 6 months ago |
Neurocrine Biosciences IncNBIX | 11 | Hold | $121.00 | -14.96% | Maintains | 6 months ago |
Karyopharm Therapeutics IncKPTI | 6 | Buy | $3.00 | +160.87% | Maintains | 7 months ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | -31.78% | Maintains | 7 months ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | +23.66% | Maintains | 8 months ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | 0.00% | Maintains | 8 months ago |
Biocryst Pharmaceuticals IncBCRX | 9 | Buy | $10.00 | +59.24% | Reiterates | 8 months ago |
Galapagos NvGLPG | 9 | Hold | $41.00 | N/A | Maintains | a year ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 3 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 4 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 6 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 7 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.